生物标志物 生物标志物
Rifa Sanjida Punnota1, Paul Edison1,2
1Imperial College London, London, Greater London, United Kingdom.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
对阿尔茨海默病生物标志物 (如Tau,低代谢和缩) 的新型全球测量显著地比传统方法更好地预测认知. 这些全球指标为临床试验提供了更好的量化.
科学领域:
- 神经成像是一种神经成像.
- 阿尔茨海默氏症疾病研究研究
- 生物标志物量化量化
背景情况:
- 阿尔茨海默病 (AD) 涉及β-粉样蛋白 (Aβ) 和陶沉积,导致认知能力下降.
- 目前对AD生物标志物的兴趣区域 (ROI) 分析有局限性,包括潜在的错误负面结果.
- 开发了新的"全球"措施,以克服在量化AD病理方面的ROI限制.
研究的目的:
- 调查用于量化Aβ,Tau,葡萄糖低代谢和灰质缩的新型"全球"措施的实用性.
- 为了比较全球措施的预测性能与AD认知功能的传统ROI分析.
- 评估全球措施对未来阿尔茨海默病临床试验的潜力.
主要方法:
- 分析了2596个扫描 (PET和MRI) 743名参与者在AD频谱的分析.
- 生成标准化吸收值比率 (SUVR) 和基于voxel的形态学 (VBM) 图像.
- 通过单个对象的voxel-wise分析和对照对照来计算"全球"措施 (全球皮层Tau负荷,Aβ负荷,低代谢,GM缩).
主要成果:
- 全球指标显著预测了参与者的基线认知能力.
- 全球皮质负荷表现优于传统的ROI指标,是Aβ阳性个体的强有力的预测指标.
- 全球低代谢和全球转基因缩与MCI和AD参与者的全脑ROI相比,是优越的预测因素.
结论:
- 与传统方法相比,全球对Tau,低代谢和转基因缩的测量表明了优越的认知预测.
- 这些全球指标显示,在未来阿尔茨海默病临床试验中采用这些指标是有前途的.
- 全球皮层沉积可能是量化AD进展中早期沉积的最佳方法.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516